BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 34111060)

  • 1. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
    Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Variants in Rhode Island.
    Kantor R; Novitsky V; Carpenter-Azevedo K; Howison M; Manne A; Darpolor JK; Bobenchik A; Tripathi A; Huard RC; King E
    R I Med J (2013); 2021 Sep; 104(7):16-20. PubMed ID: 34279520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
    Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.
    Malden DE; Bruxvoort KJ; Tseng HF; Ackerson B; Choi SK; Florea A; Tubert J; Takhar H; Aragones M; Hong V; Talarico CA; McLaughlin JM; Qian L; Tartof SY
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1415-1419. PubMed ID: 34618801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
    Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
    BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.
    Firestone MJ; Lorentz AJ; Wang X; Como-Sabetti K; Vetter S; Smith K; Holzbauer S; Meyer S; Ehresmann K; Danila R; Lynfield R
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):278-279. PubMed ID: 33630825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023.
    Silk BJ; Scobie HM; Duck WM; Palmer T; Ahmad FB; Binder AM; Cisewski JA; Kroop S; Soetebier K; Park M; Kite-Powell A; Cool A; Connelly E; Dietz S; Kirby AE; Hartnett K; Johnston J; Khan D; Stokley S; Paden CR; Sheppard M; Sutton P; Razzaghi H; Anderson RN; Thornburg N; Meyer S; Womack C; Weakland AP; McMorrow M; Broeker LR; Winn A; Hall AJ; Jackson B; Mahon BE; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(19):523-528. PubMed ID: 37167154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
    Thompson CN; Hughes S; Ngai S; Baumgartner J; Wang JC; McGibbon E; Devinney K; Luoma E; Bertolino D; Hwang C; Kepler K; Del Castillo C; Hopkins M; Lee H; DeVito AK; Rakeman JL; ; Fine AD
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):712-716. PubMed ID: 33983915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.
    Gravagnuolo AM; Faqih L; Cronshaw C; Wynn J; Klapper P; Wigglesworth M
    EBioMedicine; 2021 Aug; 70():103540. PubMed ID: 34392145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: The concept of a comprehensive approach to monitoring and surveillance of emerging variants.
    Charkiewicz R; Nikliński J; Biecek P; Kiśluk J; Pancewicz S; Moniuszko-Malinowska AM; Flisiak R; Krętowski AJ; Dzięcioł J; Moniuszko M; Gierczyński R; Juszczyk G; Reszeć J
    Adv Med Sci; 2021 Sep; 66(2):237-245. PubMed ID: 33827042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.
    Guerrero-Preston R; Rivera-Amill V; Caraballo K; Rodríguez-Torres S; Purcell-Wiltz A; García AA; Torres RS; Zamuner FT; Zanettini C; MacKay MJ; Baits R; Salgado D; Khullar G; Metti J; Baker T; Dudley J; Vale K; Pérez G; De Jesús L; Miranda Y; Ortiz D; García-Negrón A; Viera L; Ortiz A; Canabal JA; Romaguera J; Jiménez-Velázquez I; Marchionni L; Rodríguez-Orengo JF; Baez A; Mason CE; Sidransky D
    Immun Inflamm Dis; 2022 Jun; 10(6):e634. PubMed ID: 35634961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
    Ojelade M; Rodriguez A; Gonzalez D; Otokunrin D; Ramachandruni S; Cuevas E; Moon K; Tyler CG; Freeland M; Anderson M; Haire K; Orozco Y; Scipio F; Springer Y; Prot E; Shuford JA
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):348-349. PubMed ID: 33705368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Variants in Rhode Island; May 2022 Update.
    Singh M; Novitsky V; Carpenter-Azevedo K; Howison M; Huard RC; King E; Kantor R
    R I Med J (2013); 2022 Aug; 105(6):6-11. PubMed ID: 35834172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.